New patch-based wearable defibrillator receives CE mark approval

Michael Walter | January 26, 2024 | Cardiovascular Business | Electrophysiology

Element Science Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

Element Science, a San Francisco-based medical device company, has gained CE mark approval for its new patch-based cardioverter defibrillator.

The Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) is a compact, water-resistant device for identifying irregular heartbeats in patients who face a heightened risk of sudden cardiac arrest (SCA). It was designed to be less bulky and easier to wear for long periods of time than traditional vest-type wearable cardioverter defibrillators. The Jewel P-WCD can be worn in the shower, overnight and during most physical activities, including exercise.

In addition to receiving CE mark approval, the device also gained Great Britain’s UKCA marking, which covers England, Wales and Scotland.

“Out-of-hospital SCA remains a significant problem in the United States and Europe with approximately only about 10% of patients surviving,” Uday N. Kumar, founder, president and CEO of Element Science, said in a statement. “The Jewel was developed to address the compliance issues of garment-based wearable cardioverter defibrillators by focusing on user experience design and by incorporating advanced machine learning algorithms, both of which are approaches common in consumer wearables, but relatively uncommon in medical device development.”

“Element Science is on the leading edge of leveraging advancements in machine learning, wearable technologies, and miniaturization to revolutionize the way patients receive care,” added Hank Kucheman, who was Boston Scientific’s CEO back in 2011 and now holds a place on Element Science’s board of directors. “Based on my long experience in medical technology development, the rigor of the approach with which the Jewel P-WCD was designed and tested has been validated by these approvals. The company is now well positioned to plan for delivering this lifesaving technology to patients outside the U.S.”

Element Science received these new approvals in part based on data from the Jewel IDE Study, which examined the device’s safety and effectiveness in more than 300 high-risk patients. Initial results of that study included a high rate of patient compliance and no deaths or serious device-related adverse events.

This Jewel P-WCD has not been approved by the U.S. Food and Drug Administration. It is only available as an investigational device in the United States at this time.

New vest developed by cardiologists uses advanced heart imaging to screen for sudden cardiac arrest

CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure

FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms

Changing approaches to the treatment of sudden cardiac arrest

Lawsuit blames teen’s death during flight on defibrillator issue, lack of training

Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Exec

Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.